SCIENCE/TECHNOLOGY
- Share via
Compiled by Dean Takahashi /Times staff writer
An Acquisition: Helionetics Inc. in Irvine acquired a San Diego medical laser firm, Acculase, for an undisclosed amount of Helionetics stock.
Acculase is testing a laser that could be applied for medical uses such as clearing a patient’s arteries. Acculase’s top officer is Jeffrey Lavetter, a former Helionetics executive. The laser has yet to receive government approval for that use.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
